Susquehanna International Group, LLP Praxis Precision Medicines, Inc. Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.87 - $1.71 $47,957 - $94,260	55,123 Added 36.35%	206,770 $353,000
Q2 2023 Aug 11, 2023	BUY	$0.83 - $1.18 $39,281 - $55,845	47,327 Added 45.37%	151,647 $174,000
Q1 2023 May 16, 2023	BUY	$0.8 - $4.98 $67,292 - $418,892	84,115 Added 416.31%	104,320 $84,000
Q4 2022 Feb 14, 2023	SELL	$1.88 - $36.45 $27,367 - $530,602	-14,557 Reduced 41.88%	20,205 $48,000
Q3 2022 Nov 14, 2022	SELL	$2.5 - $37.95 $98,272 - $1.49 Million	-39,309 Reduced 53.07%	34,762 $79,000
Q2 2022 Aug 15, 2022	BUY	$1.75 - $11.34 $97,797 - $633,724	55,884 Added 307.27%	74,071 $181,000
Q1 2022 May 16, 2022	SELL	$10.21 - $20.29 $86,427 - $171,754	-8,465 Reduced 31.76%	18,187 $186,000
Q4 2021 Feb 14, 2022	BUY	$16.76 - $22.99 $446,687 - $612,729	26,652 New	26,652 $525,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.